NT
NTR.US Nutrien Ltd
- Market cap
- USD 32.7B
- P/E
- 15.1x
- P/B
- 1.31x
- ROE
- 8.4%
- Dividend yield
- 3.25%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NTR.US undervalued?
Graham numberNTR.US trades 6.3% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nutrien Ltd fundamental analysis
No fundamental analysis for Nutrien Ltd yet.
Nutrien Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nutrien Ltd
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The N…
Full company profileNutrien Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nutrien Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 4.46B | 4.55B | 19.6B | 20.1B | 20.9B | 27.7B | 37.9B | 29.1B | 26.0B | 26.9B | 30.6B |
| Gross Profit | 830M | 694M | 5.39B | 5.50B | 5.24B | 9.41B | 15.4B | 8.47B | 7.53B | 8.35B | 9.01B |
| Operating Income | 459M | 209M | 414M | 1.86B | 902M | 4.78B | 10.8B | 3.86B | 2.95B | 3.87B | 4.31B |
| EBITDA | 1.16B | 903M | 2.02B | 3.67B | 2.89B | 6.58B | 12.8B | 4.89B | 4.21B | 6.15B | 6.20B |
| Net Income | 336M | 327M | 3.57B | 992M | 459M | 3.15B | 7.66B | 1.26B | 674M | 2.27B | 2.17B |
| EPS | 1.00 | 0.97 | 5.72 | 1.70 | 0.81 | 5.52 | 14 | 2.53 | 1.36 | 4.66 | 4.55 |
| Balance Sheet | |||||||||||
| Total Assets | 17.3B | 17.0B | 45.5B | 46.8B | 47.2B | 50.0B | 54.6B | 52.7B | 51.8B | 52.2B | 52.7B |
| Total Liabilities | 9.06B | 8.70B | 21.1B | 23.9B | 24.8B | 26.3B | 28.7B | 27.5B | 27.4B | 26.9B | 26.9B |
| Shareholders' Equity | 8.21B | 8.30B | 24.4B | 22.9B | 22.4B | 23.7B | 25.8B | 25.2B | 24.4B | 25.3B | 25.7B |
| Cash & Short-term Investments | 32.0M | 116M | 2.31B | 671M | 1.45B | 499M | 901M | 941M | 853M | 700M | 919M |
| Total Debt | 4.59B | 4.44B | 9.22B | 11.1B | 11.4B | 10.8B | 11.9B | 12.6B | 12.8B | 12.0B | 14.1B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 1.26B | 1.23B | 2.05B | 3.67B | 3.32B | 3.89B | 8.11B | 5.07B | 3.54B | 4.01B | 1.63B |
| Capital Expenditure | 893M | 651M | 1.51B | 1.89B | 1.55B | 1.78B | 2.44B | 2.60B | 2.15B | 2.01B | 1.75B |
| Free Cash Flow | 367M | 574M | 545M | 1.77B | 1.77B | 2.10B | 5.67B | 2.47B | 1.38B | 2.00B | -121M |
| Ratios | |||||||||||
| ROE | 4.1% | 3.9% | 14.6% | 4.3% | 2.1% | 13.3% | 29.7% | 5.0% | 2.8% | 9.0% | 8.4% |
| ROA | 1.9% | 1.9% | 7.9% | 2.1% | 1.0% | 6.3% | 14.0% | 2.4% | 1.3% | 4.3% | 4.1% |
| Net Profit Margin | 7.5% | 7.2% | 18.2% | 4.9% | 2.2% | 11.4% | 20.2% | 4.3% | 2.6% | 8.4% | 7.1% |
| Debt to Equity | 0.56x | 0.53x | 0.38x | 0.49x | 0.51x | 0.46x | 0.46x | 0.50x | 0.52x | 0.47x | 0.55x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nutrien Ltd dividends
- Dividend yield
- 3.25%
- Forward dividend
- 2.20 USD
- Payout ratio
- 46.8%
- Ex-dividend date
- Dec 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.06B | 2.18 | 46.8% |
| 2024 | USD 1.06B | 2.14 | 157.3% |
| 2023 | USD 1.03B | 2.08 | 82.0% |
| 2022 | USD 1.03B | 1.91 | 13.5% |
| 2021 | USD 1.05B | 1.83 | 33.1% |
| 2020 | USD 1.03B | 1.81 | 224.4% |
| 2019 | USD 1.02B | 1.75 | 103.0% |
| 2018 | USD 952M | 1.52 | 26.6% |
| 2017 | USD 330M | 0.98 | 100.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 0.4:1 on Jan 2, 2018.
Who owns Nutrien Ltd
- Insiders 0.15%
- Institutions 73.20%
- Public & others 26.65%
- Shares outstanding 474M
- Free float 473M
Top funds holding NTR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard Total Intl Stock Index Inv | 7.12M | 1.50% | +0.13% | Sep 2026 |
| DWS Top Dividende LD | 5.15M | 1.08% | +0.00% | Sep 2026 |
| Northern Trust MstarGlblUpstmNatrlResETF | 4.80M | 1.01% | 0.00% | Oct 2026 |
| First Eagle Global A | 4.78M | 1.01% | 0.00% | Sep 2026 |
| Vanguard Developed Markets Index Admiral | 4.70M | 0.99% | -0.37% | Sep 2026 |
| American Funds EUPAC A | 4.51M | 0.95% | -6.51% | Sep 2026 |
| RBC Canadian Dividend Fund A | 4.22M | 0.89% | 0.00% | Sep 2026 |
| Vanguard Equity-Income Inv | 4.10M | 0.86% | 0.00% | Sep 2026 |
| State Street® SPDR® S&P® Glb Ntrl Rs ETF | 3.78M | 0.80% | +0.14% | Oct 2026 |
| iShares Core S&P/TSX Cap Composite ETF | 3.43M | 0.72% | +0.17% | Oct 2026 |
| Fidelity SAI Canada Equity Index | 2.79M | 0.59% | +9.12% | Sep 2026 |
| iShares S&P/TSX 60 ETF | 2.69M | 0.57% | +0.09% | Oct 2026 |
| Scotia Canadian Dividend A | 2.57M | 0.54% | +1.19% | Jul 2026 |
| Vanguard Wellesley® Income Inv | 2.31M | 0.49% | +42.77% | Sep 2026 |
| Dimensional International Value ETF | 2.23M | 0.47% | +0.18% | Oct 2026 |
| First Eagle Overseas A | 2.03M | 0.43% | 0.00% | Sep 2026 |
| TD Canadian Equity - I | 1.92M | 0.40% | 0.00% | Jun 2026 |
| JPMorgan BetaBuilders Canada ETF | 1.85M | 0.39% | +0.09% | Oct 2026 |
| iShares S&P/TSX Composite High Div ETF | 1.83M | 0.39% | 0.00% | Oct 2026 |
| Vanguard Windsor Investor Shares | 1.81M | 0.38% | +27.44% | Sep 2026 |
Top institutions holding NTR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Royal Bank of Canada | 32.9M | 6.92% | +6.09% | Jun 2026 |
| Arnhold & S. Bleichroeder Advisers, LLC | 19.9M | 4.20% | +99.65% | Jun 2026 |
| Vanguard Capital Management, LLC | 14.7M | 3.10% | -0.07% | Jun 2026 |
| Bank of Montreal | 13.8M | 2.90% | +7.09% | Jun 2026 |
| BMO Capital Markets Corp. | 13.8M | 2.90% | +7.09% | Jun 2026 |
| Wellington Management Company LLP | 10.4M | 2.19% | -35.44% | Jun 2026 |
| Deutsche Bank AG | 9.35M | 1.97% | +9.58% | Jun 2026 |
| Mackenzie Investments | 7.88M | 1.66% | +1.11% | Jun 2026 |
| 1832 Asset Management L.P | 7.18M | 1.51% | +12.19% | Jun 2026 |
| TD Asset Management Inc | 6.71M | 1.41% | -27.53% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 6.22M | 1.31% | +3.59% | Sep 2026 |
| Arrowstreet Capital Limited Partnership | 6.03M | 1.27% | -49.01% | Jun 2026 |
| Manufacturers Life Insurance Co | 5.97M | 1.26% | +30.79% | Jun 2026 |
| Capital Research & Mgmt Co - Division 3 | 5.91M | 1.24% | -13.52% | Sep 2026 |
| Canada Pension Plan Investment Board | 5.71M | 1.20% | +46.34% | Jun 2026 |
| TD Waterhouse Canada Inc | 5.52M | 1.16% | +2.09% | Jun 2026 |
| CIBC World Markets Inc. | 5.51M | 1.16% | +5.98% | Jun 2026 |
| Geode Capital Management, LLC | 5.46M | 1.15% | +11.28% | Jun 2026 |
| NORGES BANK | 5.41M | 1.14% | -19.06% | Jun 2026 |
| FMR Inc | 5.38M | 1.13% | -24.37% | Jun 2026 |
Nutrien Ltd company profile
- Company name
- Nutrien Ltd
- Ticker
- NTR.US
- ISIN
- CA67077M1086
- Exchange
- USA Stocks
- Listed since
- Jan 2, 2018
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 25,500
- Fiscal year end
- December
- Address
- 211 19th Street East, Saskatoon, SK, Canada, S7K 5R6
- Phone
- 306-933-8500
- Website
- nutrien.com
About Nutrien Ltd
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns and operates ammonia production facilities that offers ammonia, urea, ammonium nitrate (UAN), urea solutions, nitric acid, and ammonium nitrate, as well as environmentally smart nitrogen and ammonium sulfate. The Phosphate segment manufactures and sells solid and liquid phosphate fertilizers, phosphate feed, and purified phosphoric acid, which is used in feed and industrial products. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Nutrien Ltd management
10- Mr. Kenneth A. SeitzPresident, CEO & Non-Independent Director · born 1970
- Mr. Mark ThompsonExecutive VP & CFO
- Ms. Noralee M. Bradley LLB.Executive VP of External Affairs, Chief Legal Officer & Corporate Secretary
- Mr. Christopher Pringle ReynoldsExecutive Vice President of Global Sales · born 1974
- Mr. Jeff HolzmanVice President of Investor Relations
- Mr. Andrew J. KelemenExecutive VP of Corporate Development & Chief Strategy Officer
- Ms. Sarah J. WaltersExecutive VP of IT & Chief People Officer
- Jason NewtonHead Economist
- Mr. Tim DahlheimerSenior Vice President of Safety, Health, Environment & Security
- Mr. Trevor BergSenior Vice President of Upstream, Potash & Phosphate Operations